5
Clinical Trials associated with HSK-44459A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis
The purpose of this study is to assess the efficacy and safety of HSK44459 in adults with Atopic Dermatitis
HSK44459片在健康受试者中的安全性、耐受性、药代动力学的I期临床研究
[Translation] Phase I clinical study on the safety, tolerability and pharmacokinetics of HSK44459 tablets in healthy subjects
评价HSK44459片在健康受试者中单次和多次给药的安全性和耐受性;
[Translation] To evaluate the safety and tolerability of single and multiple doses of HSK44459 tablets in healthy subjects;
/ Not yet recruitingPhase 2 A Multi-center, Randomised, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HSK44459 Tablets in Patients With Behçet's Disease
This is a phase 2, multi-center, randomised, double-blind, placebo-controlled study with an equal randomization among the HSK44459 dose 1, dose 2 and placebo treatment groups. The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.
100 Clinical Results associated with HSK-44459
100 Translational Medicine associated with HSK-44459
100 Patents (Medical) associated with HSK-44459
100 Deals associated with HSK-44459